Latest News in the pharma Industry

Market News

Biogen agrees to pay Forward Pharma $1.25 billion

Biogen agrees to pay Forward Pharma $1.25 billion

17 Jan 2017

The settlement and license agreement will strengthen Biogen's IP for leading oral therapy for multiple sclerosis.

Read more 
Suliqua approved in the EU for the treatment of adults with type 2 diabetes

Suliqua approved in the EU for the treatment of adults with type 2 diabetes

17 Jan 2017

Suliqua will be delivered in two pre-filled SoloSTAR pens, providing different dosing options that may help answer individual market and patient insulin needs.

Read more 
MicroJect Reactor technology to take centre stage in new partnership

MicroJect Reactor technology to take centre stage in new partnership

16 Jan 2017

leon nanodrugs' MJR technology offers reformulation options that address API solubility issues.

Read more 
A-Skin secures patent for groundbreaking skin engineering therapy

A-Skin secures patent for groundbreaking skin engineering therapy

16 Jan 2017

WHF therapy can be directly applied on a wound to stimulate the natural human wound healing process.

Read more 
Ipsen to acquire oncology assets from Merrimack Pharmaceuticals

Ipsen to acquire oncology assets from Merrimack Pharmaceuticals

16 Jan 2017

Transaction includes US commercialization rights for Onivyde for metastatic pancreatic cancer in adult patients.

Read more 
Tesaro receives CRL for rolapitant IV from FDA

Tesaro receives CRL for rolapitant IV from FDA

15 Jan 2017

No concerns raised by FDA related to the rolapitant IV efficacy or safety profile and additional clinical studies are not required.

Read more 
New-generation mealtime insulin approved in Europe

New-generation mealtime insulin approved in Europe

14 Jan 2017

Novo Nordisk to launch Fiasp in first half of 2017.

Read more 
VivaGel BV granted QIDP and Fast Track designation by FDA

VivaGel BV granted QIDP and Fast Track designation by FDA

14 Jan 2017

Product receives designations for both the BV treatment and prevention indications.

Read more 
Sartorius Stedim Biotech opens a new validation service laboratory at its Shanghai site

Sartorius Stedim Biotech opens a new validation service laboratory at its Shanghai site

12 Jan 2017

Comprehensive validation services for the Chinese market.

Read more 
Merck Licenses four oncology R&D programs from Vertex

Merck Licenses four oncology R&D programs from Vertex

12 Jan 2017

All programs (two promising clinical-stage programs targeting DNA damage and repair, and two novel pre-clinical programs) have first-in-class and best-in-class potential.

Read more 
US Court of Appeals rules in Lilly's favour on Alimta vitamin regimen patent

US Court of Appeals rules in Lilly's favour on Alimta vitamin regimen patent

12 Jan 2017

If the patent is ultimately upheld through all remaining challenges, Alimta would maintain US exclusivity until May 2022.

Read more 
Lilly and Merck expand immuno-oncology collaboration

Lilly and Merck expand immuno-oncology collaboration

11 Jan 2017

New study to evaluate combination of Lartruvo and Keytruda.

Read more